CT Scanner Market Size To Surpass $8.40 Billion By 2027 | CAGR: 6.4% | Polaris Market Research

New York City, 20 Jul 2020: The global CT Scanner market size is expected to reach USD 8.40 billion by 2027 according to a new study by Polaris Market Research.Computed tomography is an imaging devices which enables users to look inside the specimen without cutting it. It utilizes computer systems and rotating X-rays machines to produce cross sectional images. In medical, it offers images of blood vessels, bones, and soft tissues to find any ailments or bone fractures in the human body. CT scanning is non-invasive, fast, accurate, and painless procedure. In emergency situation, it provides details of internal injuries and hemorrhage, which saves many human lives.

The prominent factors favoring the market growth include improvement in the Scanner technology, miniaturization resulting in portable CT Scanner, and rising prevalence in bone-related disorders coupled with road traffic accidents. According to the statistics published by the U.S. Center for Disease and Control (CDC), around 30 million people take part in sports related activities in the U.S. alone. Of this, individuals aged 15 to 20 accounted for around 2 million injuries and more than 30,000 hospital admissions per year.

Request for sample pages 

Moreover, many start-ups are employing artificial intelligence (AI) for an accurate diagnosis. According to the study published in NVIDIA, AI could significantly drop error rate in cancer diagnosis by more than 85 per cent. In line with this, Aidoc, an Israel based start up is employing AI to decipher medical scans and in 2016, the U.S. based AI medical imaging platform Behold.ai, came up with its proprietary “red dot algorithm”. This algorithm has 90 per cent accuracy and faster scanning capability.

Market participants such as CurveBeam, Hitachi Medical Corporation, Neusoft, Samsung, Canon Medical Systems, GE Healthcare, Medtronic Inc., Accuray, Koning Corporation, Xoran, Koninklijke Philips, Carestream, Planmed Oy, Siemens Healthineers, Shenzhen Anke High-Tech, and United Imaging Technologies are some of the key players operating in the concerned market.

The players in the market are competing on different parameters such as strategic partnerships and agreements, exclusive service offerings, after-sales service, providing financing options, and warranties. In cost-sensitive untapped markets, the players are penetrating through government contracts, leasing and exclusive collaborations.

Read More : https://www.polarismarketresearch.com/industry-analysis/ct-scanner-market

Blood Glucose Monitoring Device Market Size Estimated to Reach USD 2.61 billion by 2026

New York, NY 24 Jan 2020  :The Blood Glucose Monitoring Device market is anticipated to reach over USD 2.61 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the orthopedic treatment dominated the global Blood Glucose Monitoring Device market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue in 2017.

The increasing need for home care diagnosis and real time data by the end users to primarily drive the blood glucose monitoring device market during the forecast period. These devices have potential market due to the rising technology advancements in this industry during the forecast period. Moreover, the major supporting factor for this market growth is the number of populations suffering from diabetes. According to the World Health Organization (WHO), approximately there were direct deaths if 1.6 million in 2015, and this number is attributed to rise by 2030 making diabetes the 7th leading cause of death globally.

Furthermore, the changing life style of the people, and rising preference to the sedentary life style to also support the market growth in the coming years. However, lack of awareness, limited use of these devices, and no proper reimbursements regulation by the government would impede the market growth during the forecast period.

North America generated the highest revenue in the Blood Glucose Monitoring Device market in 2017, and is expected to be the leading region globally during the forecast period. Increasing demand, rising patient awareness for proper self-diagnosis methods, which saves the time, money, and provides accurate real-time data about the patient health. Also, decreasing cost & time of treatment, and continuous research and development in the same field to also boost the market growth in coming years. While, Asia Pacific blood glucose monitoring device market  is supposed to the fastest growing market during forecast period.

The key players operating in the Blood Glucose Monitoring Device market include Abbott Laboratories, Terumo Corporation, ARKRAY Inc., Medtronic Plc., Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, Novo Nordisk A/S, Becton, Dickinson and Co., Sanofi, Bayer AG, Ypsomed AG. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Read More: https://www.polarismarketresearch.com/industry-analysis/blood-glucose-monitoring-device-market

Sleep Apnea Devices Market Size to Reach $10.23 Billion by 2026

New York, NY 22 Jan 2020 :The global Sleep Apnea Devices Market size is anticipated to reach USD 10.23 billion by 2026 growing at a CAGR of 7.9% from 2018 to 2026 according to a new report published by Polaris Market Research.  The report provides insights on the current market scenario and the future prospects. In 2017, the Positive airway pressure (PAP) dominated the global Sleep Apnea Devices industry, in terms of revenue. North America was to be the leading contributor to the global market revenue in 2017.

Sleep apnea is an ailment which befalls when the brain as well as body obtain inadequate amount of oxygen where breathing process is interfered while sleeping. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea which is majorly triggered by airway blockage. Other forms of sleep apnea are central sleep apnea, and complex sleep apnea syndrome. In order to avoid such disease, it is essential to perform diagnostic tests on the patient to classify the appropriate therapeutic devices for treatment. Sleep apnea is extensively observed in the elderly population. There are multiple instances where sleep apnea is kept un-diagnosed due to factors such as non-specific exhibition of the disorder and lack of awareness amongst the patients..

Request for Sample

 Growing frequency of this disease along with the increasing need for appropriate diagnosis and effective treatment, increasing responsiveness among individuals, and growing geriatric population are some of the major factors encouraging the industry growth. Moreover, technological advancements augmenting comfort and safety is expected to enhance the usage of device rates especially in developed economies such as North America, which in turn is estimated to drive the market growth.

The sleep apnea diagnosis industry has witnessed rapid surge during the past decade. The growth is been attributed to the continuous development in sleep apnea device usage. According to the World Health Organization (WHO) reports, about 100 million individuals are suffering from sleep apnea. In addition, obstructive sleep apnea and is a chronic disease that unfavorably affects health. According to the National Healthy Sleep Awareness Project reports, around 25 million people are affected by this disease alone in the U.S.

Occurrence of sleep apnea surges the risk of other ailments such as abnormal glucose metabolism, depression, diabetes, high blood pressure, systemic hypertension, heart disease, and strokes. This all disorders further rises the total healthcare cost weight on the nation. Increasing consciousness regarding the sleep apnea along with welfare of using sleep apnea devices are anticipated to upsurge the revenue growth during the near future.

The North America was estimated to hold the highest market share during 2017. The large market share is majorly attributed to due to the high occurrence of Sleep-Disordered Breathing (SDB). Moreover, there is also a growing awareness amongst the for the novel and technologically advanced sleep apnea devices that are driving the growth of market growth in North America.

Asia Pacific market is anticipated to be the fastest growing industry during the forecast period. Growing number of clinics and large number of undiagnosed patient pool are expected to form lucrative growth opportunity in the market. Key players present in this region are focusing on constructing favorable policies towards enhancing the consumer pool through introduction of advanced as and cost-effective devices which in turn is expected to provide robust growth opportunities in the market during the forecast period.

The well-known companies profiled in the Sleep Apnea Devices market report include Fisher & Paykel Healthcare (New Zealand), Koninklijke Philips (Netherlands), ResMed (US), Compumedics (Australia), Whole You (US), BMC Medical (China), Braebon Medical (Canada), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (US), and SomnoMed (Australia). These companies launch new products and collaborate with other leaders in the market to innovate and launch new products to meet the increasing needs and requirements of consumers.

Read More: https://www.polarismarketresearch.com/industry-analysis/sleep-apnea-devices-market

Cosmeceutical Market size is expected to reach USD 98.7 billion by 2026 | Polaris Market Research

New York City, 24 January 2020: The global Cosmeceutical Market size is expected to reach USD 98.7 billion by 2026 according to a new study by Polaris Market Research. The market for cosmeceuticals includes the growing category of cosmetic products with drug-like advantages. These products are rapidly outperforming the growth rate of all other product sections in the personal care and cosmetics sector. The various kinds of cosmeceuticals on the market include lip care, hair care, whitening of the tooth, skin care, injection and others. Of these, the section of skin care retains a major share and is followed by the segment of hair care. Anti-aging products are most common in the skin care segment, resulting in peak gross revenue.

Over-the-counter cosmeceutical medicines are accessible and are usually used as part of daily routine skin care therapy to improve texture, acne, pigmentation, skin tone, and fine lines. Some of the prevalent components used in cosmeceutical products are retinoids, antioxidants, exfoliants, peptides and proteins, and botanical extracts.

Request For Sample

Growing consumer awareness of appearance, increasing preference for natural / organic goods, increasing disposable income in emerging economies, the accessibility of technologically sophisticated and user-friendly cosmeceutical products are driving this market’s development. On the other side, it is probable that deceptive marketing methods will restrict market growth. It is anticipated that the increasing number of middle-aged people, a fast-paced life and a burgeoning urban population will further drive market demand. Also stimulating development was the availability on the market of a plethora of superior quality and premium price cosmeceutical products.

Cosmeceuticals products are used in a host of other tasks, such as tooth whitening, skin irritation, skin lightening. Putting a roadblock on the worldwide cosmeceuticals market’s development route is the fast development of various therapy alternatives. The emergence and popularity of natural and organic products is a main trend observed on the worldwide cosmeceuticals market.

In addition, females are constantly struggling with sedentary and hectic lifestyles of working, so they get far less time to put on daily makeup. This has forced them to purchase medicinally-advantaged cosmetic products to prevent using make-up. In addition, customers worldwide are conscious of the skin’s benefits of antioxidants, organic ingredients, and peptides. Increasing beauty and health awareness among rich and knowledgeable customers has therefore resulted in increased market growth.

Some of the key players in the market are AVON, Procter & Gamble, Croda International Plc., L’Oréal, Corporation, Beiersdorf, Johnson & Johnson, Allergan, Unilever, Estee Lauder Inc, BASF SE, and Bayer AG among others.

Browse Full Research Report on "Cosmeceutical Market" @ https://www.polarismarketresearch.com/industry-analysis/cosmeceutical-market

Platinum Based Cancer Drugs Market Size is Estimated to Reach USD 1,814.1 Million by 2026 | Polaris Market Research

New York City, 24 January 2020: The global Platinum Based Cancer Drugs Market  size is expected to reach USD 1,814.1 Million by 2026 . Drugs based on platinum have become a major component of cancer therapy; about half of all patients undergoing chemotherapy receive a platinum drug. The widespread use of platinum agents in cancer treatment started with Barnett Rosenberg’s discovery of cisplatin’s antineoplastic activity in the 1960s.

According to the National Cancer Institute, the instances of new cases per year is expected to rise to 23.6 million by 2030. Nevertheless, the major limitations of this industry worldwide are the drug-related side effects and resistance growth. Recent developments in platinum based cancer drugs include the development of analog platinum drugs such as platinum carrier molecule complexes to boost targeted concentration of drugs in cancer tumor. This increasing number of cancer instances is expected to drive the growth of the global platinum cancer drug market during the forecast period.

Request For Sample

The platinum based cancer drugs market can be categorized in terms of product type as oxaliplatin, cisplatin, carboplatin, and others. Cisplatin is the most commonly used for treating certain malignancies. It is particularly effective in testicular cancer and is intravenously administered. Carboplatin, a derivative of cisplatin, is used to treat multiple cancers like ovaries, lungs, brains, and so on. Cisplatin’s segment maintained the largest market share in 2018 and is expected to remain dominant over the forecast period. Based on application, the global market is divided into ovarian, lung, testicular, colorectal, and other cancer. The lung cancer segment dominated the market in 2018 due to the high incidence among the world’s population.

Due to enhanced disease prevalence, enhanced awareness, increased per capita income, and enhanced health care infrastructure, the Asia Pacific market is anticipated to develop at the largest CAGR. North America dominated the global market in 2018 due to the high incidence of cancer in the region, developments in these drugs and recent FDA approvals. United States is the world’s largest drug market. This has led to the dominance of North America in the global platinum cancer drug market. The U.S. pharmaceutical industry is the largest domestic market in the world. It is the world’s biggest continental pharmaceutical market together with Canada and Mexico. More than 45 percent of the worldwide pharmaceutical industry is held by the United States alone. This share was valued at approximately $446 Million in 2016. Many of the top worldwide firms are from the U.S. In 2016, six out of the top 10 firms were based on sheer pharmaceutical income from the United States.

Major players in the platinum cancer drug market include Sanofi, Pfizer, Inc., Mylan N.V., Ask-Pharma, Sun Pharmaceutical Industries Ltd., Accord Healthcare, Novartis AG, Teva Pharmaceutical Industries Ltd., Guizhou YiBai Pharmaceutical Co., Ltd., SK Chemicals, Qilu Pharmaceutical Co., Ltd., Dr. Reddy’s Laboratories Ltd., Debiopharm Group, and Jiangsu Hengrui Pharmaceutical Co., Ltd.

Browse Full Research Report on "Platinum Based Cancer Drugs Market " @ : https://www.polarismarketresearch.com/industry-analysis/platinum-based-cancer-drugs-market

Global Freeze Drying Equipment Market Size is Estimated to Reach USD 3.11 Billion by 2026 | Polaris Market Research

New York City, 24 January 2020: The global Freeze Drying Equipment Market size is expected to reach USD 3.11 Billion by 2026 according to a new study by Polaris Market Research Freeze drying is the effective way of drying various heat sensitive, unstable and aqueous products. Lyophilization is used in pharmaceuticals manufacturing in the healthcare industry. Freeze drying process is used to conserve the decay of food materials by slowing down the decomposition process. This process preserves the quality, taste and texture of wide range of products. This is the reason for its wide usage in food processing industry and healthcare industry.

The rapidly growing food processing industry is expected to be one of the major reasons for the augment in demand for freeze drying equipment over the forecast period. In addition to this, the growing healthcare industry is also anticipated to propel the growth of freeze-drying equipment market over the forecast period. Rise in awareness pertaining to various benefits such as enhanced efficiency with regards to air drying and desiccant drying associated with these products is also anticipated to drive the growth of this market over the forecast period.  The rapidly growing urbanization coupled with increasing consumption of preserved foods is also anticipated to fuel the growth of freeze-drying equipment market. Various companies in the market have adopted mergers and acquisitions as a key developmental strategy.

Request For Sample

Industrial freezers hold a major share in the global market. This is mainly due to its usage in various industrial areas because of its high efficiency. Pharmaceuticals and food processing industries are anticipated to hold a massive share in the global showcase. However, the food processing segment is expected to witness highest growth rate over the forecast period. This equipment are widely used in pharmaceutical industry to store and stable the drugs and also to preserve biologicals such as viruses & bacteria, proteins, enzymes, and penicillin.

Asia Pacific is expected to witness exponential growth in demand for freeze drying equipment market over the forecast period. There has been increase in awareness activities pertaining to benefits associated with the usage of freeze drying equipment amongst the industries in this region. This in turn, has led to augment in demand for this equipment in the recent years, thus fueling the growth of the market. In addition to this, North America and Europe are expected to also contribute a major share in the global market owing to the existence of leather tanneries. Hence, the market size is anticipated to witness significant growth in these regions.

The key leading players in the market include Tofflon Science and Technology Co., Ltd, GEA Group, Labconco Corporation, Azbil Corporation, EYELA, Harvest Right, Millrock Technology, Inc., SP Scientific, Yamato Scientific America Inc., Z-SC1 Corp., Mechatech Systems Ltd., OctoFrost Group and USIFROID among others. These key market players are continuously focusing on R&D activities in order to gain major market share. In addition to this, the key market players in have adopted the strategy of signing agreements with other small players so as to geographically increase the visibility of their products.

Browse Full Research Report on "Freeze Drying Equipment Market" @ : https://www.polarismarketresearch.com/industry-analysis/freeze-drying-equipment-market

CBD Oil Market Size To Reach $ 3,095.3 Million By 2026 | CAGR: 30.9%

New York City, 24 January 2020:The global CBD Oil Market size is expected to reach USD 3,095.3 million by 2026 according to a new study by Polaris Market Research. The report “CBD Oil Market Share, Size, Trends, Industry Analysis Report By Product (Hemp Based and Marijuana Based), By Application (Pharmaceuticals, Food & Beverages, Cosmetics and Others); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online, Others); By Regions, Segments & Forecast, 2019 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Flexibility of CBD oil thus resulting in a wide variety of applications, health benefits such as ability to boost cognitive abilities, anti-inflammatory properties, among others, and information outburst through a variety of platforms including social media are benefitting the CBD oil market demand. Development of novel products such as CBD oil infused honey and aggressive marketing strategies adopted to promote the same is also expected to benefit the overall market growth.

Request for a sample

In the past, CBD related research was restricted to the treatment of severe diseases such as cancer and epilepsy and this put limitations on the usage in other avenues such as cosmetics. However, with multinationals taking interest in the product, the research horizon widened and properties such as anti-inflammatory were discovered which led to the usage of the oil not just by health provider brands but by wellness brands as well. This widened usage coupled with the rising preference for preventive healthcare has fueled CBD oil market growth across the globe.

Rise in millennial population is also benefitting the market demand. Bath soaps, lip gloss, face creams, lotions, serums, medicines for curing muscle pains are some of the products that are appealing to this segment of customers. Furthermore, companies are adopting SEO centric strategies to create online awareness regarding CBD oil products among these millennials. This category of customers is looking to boost their cognitive ability or health functions through usage of novel ways and CBD oil infused products fits this demand perfectly.

North America emerged as the largest market for CBD oil in 2018 and is expected to maintain its dominance over the forecast period. Strong presence of companies in the US, high awareness regarding CBD oil usage, availability of a wide variety of products as well as efficient distribution channels leading to easy availability are some of the factors benefitting the regional market demand. Acquisition of companies having good brand recall and brand awareness by multinationals is a key market scenario in the region.

The key players in the market for CBD oil include ENDOCA, Isodiol, Medical Marijuana, Cannoid., Canopy Growth Corporation, Elixinol Group, Folium Biosciences, Diamond CBD, NuLeaf Naturals, PharmaHemp, Aphria Inc. and Gaia Botanicals among others. Development of distribution channels, novel product development and aggressive marketing campaigning are some of the success factors in the industry.

Read More : https://www.polarismarketresearch.com/industry-analysis/cbd-oil-market

Home Healthcare Market Worth $447.6 Billion by 2025 | CAGR: 8.3%

New York, NY 7 Oct 2019 : The global home healthcare market is estimated to reach USD 447.6 billion by 2025 growing at a CAGR of 8.3% during the forecast period, according to a new study published by Polaris Market Research. The report provides an extensive analysis of present market dynamics and predicted future trends.

Request for Sample

The rising geriatric population globally and increasing workforce of home healthcare service providers. Moreover, increasing demand for home healthcare, and large number of population suffering from chronic disease that require long term care would retain the home healthcare market. While, increasing mergers and acquisitions between the manufacturers to tap the potential market will also influence the entire industry. However, high cost of service providers can hinder market in the near future.

The major players in the market include GE Healthcare, McKesson Corporation, Roche Holding AG, Linde Corporation, Abbott Laboratories, Omron Healthcare, Philips Healthcare, A&D Company, Kindred Healthcare, LHC Group, Fresenius, Kinnser Software.

 Regionally, North America holds the major share of the global home healthcare market. This report cover the following regions: North America, Europe, Asia-Pacific, Latin America, and MEA. In terms of geography, North America accounted majority share in the global market due to huge number of older population that require home care. While, Asia Pacific has a profitable market during the forecast period. This growth is primarily driven by the increasing investment and awareness for home care services in the developing countries on improving the healthcare infrastructure.

Read More: https://www.polarismarketresearch.com/industry-analysis/home-healthcare-market

Hemostasis and Tissue Sealing Agents Market worth $6,632.9 Million by 2026 |CAGR of 7.8 %

New York, NY 4 Oct 2019 :The global Hemostasis and Tissue Sealing Agents market size is expected to be worth USD 6,632.9 million by 2026 growing at a CAGR of 7.8% from 2019 to 2026, as per new research report published by Polaris Market Research.  During 2017, among product types, Topical hemostats segment was observed to capture the largest market shares in terms of revenue. Among the regional markets, North America region accounted for a dominating share and the regional market in Asia Pacific is anticipated to witness fastest growth during the forecast period.

Increase in demand across the world for minimal invasive surgeries along with continual rise in geriatric patients with chronic conditions are factors responsible for the estimated growth in this market. Also, as new hemostats and tissue sealants are being introduced in the market, they are witnessing increased preference as these products eliminate any issues and risks associated with tissue contamination.

Request for Sample Pages

Moreover, injuries caused by sports activities, spinal conditions coupled with growing emphasis on effective measures for blood loss management during surgeries are expected to have further positive influence on adoption of these products. The significant rate of growth in amount of hospitals and surgical centers in markets of emerging economies present encouraging opportunities for manufacturers of hemostats and tissue sealant agents.

The regional analysis section in this report covers North America, Europe, Asia Pacific, Latin America, and Middle East & Africa regional markets. North America Hemostasis and Tissue Sealing Agents market held the leading position among all regional markets and is expected to maintain its dominating position throughout the forecast period. However, market in Asia Pacific region is expected to grow at the highest rate; the growth in this region is majorly expected due to rapidly improving healthcare infrastructure, rising medical tourism, and growing aging population in countries such as China and India.  

The FDA has approved fibrin sealants as broad level hemostats for use in surgical procedures. These are popular and conveniently used in Myocardial Infarction (MI) surgeries and specifically in cases of patients having clotting disorders. Major companies in the global hemostasis and tissue sealing agents market include Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Baxter International Inc., BD Bard, CryoLife, Inc., Ethicon, GELITA MEDICAL GmbH, Medtronic, Pfizer Inc., Smith & Nephew plc, and Stryker Corporation.

Read More: https://www.polarismarketresearch.com/industry-analysis/hemostasis-tissue-sealing-agents-market